Aware Super Pty Ltd as trustee of Aware Super Has $35.20 Million Holdings in Zoetis Inc. $ZTS

Aware Super Pty Ltd as trustee of Aware Super raised its position in Zoetis Inc. (NYSE:ZTS) by 3.8% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 225,248 shares of the company’s stock after acquiring an additional 8,200 shares during the period. Aware Super Pty Ltd as trustee of Aware Super owned approximately 0.05% of Zoetis worth $35,199,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in ZTS. Nuveen LLC acquired a new stake in Zoetis in the first quarter valued at approximately $616,375,000. Mackenzie Financial Corp grew its stake in Zoetis by 4,158.3% in the first quarter. Mackenzie Financial Corp now owns 1,824,967 shares of the company’s stock valued at $300,481,000 after acquiring an additional 1,782,110 shares during the period. Polen Capital Management LLC grew its stake in Zoetis by 17.6% in the first quarter. Polen Capital Management LLC now owns 8,796,847 shares of the company’s stock valued at $1,448,401,000 after acquiring an additional 1,313,653 shares during the period. Amundi boosted its position in shares of Zoetis by 30.8% during the first quarter. Amundi now owns 3,595,628 shares of the company’s stock valued at $575,691,000 after buying an additional 846,909 shares during the last quarter. Finally, OVERSEA CHINESE BANKING Corp Ltd boosted its position in shares of Zoetis by 475.9% during the first quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 900,261 shares of the company’s stock valued at $148,228,000 after buying an additional 743,926 shares during the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the company. Argus reaffirmed a “buy” rating and set a $190.00 target price on shares of Zoetis in a research report on Tuesday, September 9th. Leerink Partnrs cut Zoetis from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 17th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Zoetis in a research report on Wednesday, October 8th. Leerink Partners cut Zoetis from an “outperform” rating to a “market perform” rating and cut their target price for the company from $180.00 to $155.00 in a research report on Thursday, July 17th. Finally, Stifel Nicolaus cut Zoetis from a “buy” rating to a “hold” rating and cut their target price for the company from $165.00 to $160.00 in a research report on Wednesday, June 18th. Four investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, Zoetis presently has a consensus rating of “Hold” and an average price target of $196.71.

Zoetis Stock Performance

Shares of Zoetis stock opened at $142.08 on Thursday. The business’s fifty day simple moving average is $148.89 and its 200 day simple moving average is $154.03. The firm has a market capitalization of $62.97 billion, a P/E ratio of 24.45, a price-to-earnings-growth ratio of 2.30 and a beta of 0.90. Zoetis Inc. has a 12 month low of $139.34 and a 12 month high of $196.55. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $1.76 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.14. The business had revenue of $2.46 billion for the quarter, compared to analyst estimates of $2.41 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.Zoetis’s quarterly revenue was up 4.2% compared to the same quarter last year. During the same period last year, the company posted $1.56 earnings per share. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, analysts anticipate that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 2nd. Investors of record on Friday, October 31st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date is Friday, October 31st. Zoetis’s dividend payout ratio (DPR) is 34.42%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.